Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.23.21 - Rhizopuspepsin

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenoma
A novel aspartate protease gene, ALP56, is related to morphological features of colorectal adenomas.
Alzheimer Disease
Molecular Docking and 3D Qsar Studies of C000000956 as a Potent Inhibitor of Bace-1.
Multiple e-Pharmacophore Modeling Combined with High-Throughput Virtual Screening and Docking to Identify Potential Inhibitors of ?-Secretase(BACE1).
Overview of pepsin-like aspartic peptidases.
Arthritis, Rheumatoid
Lysosomal peptidases and glycosidases in rheumatoid arthritis.
Asthma
Recognition of Fungal Protease Activities Induces Cellular Activation and Eosinophil-Derived Neurotoxin Release in Human Eosinophils.
Breast Neoplasms
Overview of pepsin-like aspartic peptidases.
Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.
Carcinoma
Diagnostic and Prognostic Role of Immunohistochemical Expression of Napsin-A Aspartic Peptidase in Clear Cell and Papillary Renal Cell Carcinoma: A Study Including 233 Primary and Metastatic Cases.
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma.
Carcinoma, Renal Cell
Diagnostic and Prognostic Role of Immunohistochemical Expression of Napsin-A Aspartic Peptidase in Clear Cell and Papillary Renal Cell Carcinoma: A Study Including 233 Primary and Metastatic Cases.
cathepsin l deficiency
Epidermal differentiation: the role of proteases and their inhibitors.
Chagas Disease
Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy.
Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.
Chromoblastomycosis
Fonsecaea pedrosoi Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase Inhibitors.
Coinfection
Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.
Colitis
Chlorogenic Acid Suppresses miR-155 and Ameliorates Ulcerative Colitis through the NF-?B/NLRP3 Inflammasome Pathway.
Colonic Neoplasms
Increased expression of cathepsin D is required for L1-mediated colon cancer progression.
Colorectal Neoplasms
A novel aspartate protease gene, ALP56, is related to morphological features of colorectal adenomas.
Insulin Resistance
Altered amyloid precursor protein processing regulates glucose uptake and oxidation in cultured rodent myotubes.
Leishmaniasis
Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy.
Neoplasms
A novel aspartate protease gene, ALP56, is related to morphological features of colorectal adenomas.
Complex modulation of peptidolytic activity of cathepsin D by sphingolipids.
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma.
Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.
Therapeutic potential of HIV protease-activable CASP3.
Netherton Syndrome
Epidermal differentiation: the role of proteases and their inhibitors.
Opportunistic Infections
The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi.
Papillon-Lefevre Disease
Epidermal differentiation: the role of proteases and their inhibitors.
Stomach Ulcer
Overview of pepsin-like aspartic peptidases.